This presentation aims to provide an overview of the mRCC patient journey and the challenges clinicians face. To explore how clinical decisions are taken today and the factors that affect our current choices. To examine the emerging role of IO combinations in mRCC management, and discuss our future patient selection dilemmas and unanswered questions. From the Kidney Cancer Association International Symposium 2019 in Dubrovnik
Right here, right patient, right treatment: Now and next
